je.st
news
Eli Lilly, Incyte drug fares well in late-stage research
2015-09-29 16:11:28| Biotech - Topix.net
A potential rheumatoid arthritis treatment from Eli Lilly and Incyte fared better than another drug in late-stage testing, and the drugmakers are moving closer to seeking regulatory approval to sell it. Lilly said Tuesday that early results from a study that enrolled around 600 patients showed that its oral medication, baricitinib, proved superior to the established treatment methotrexate.
Tags: research
drug
eli
lilly
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||